K. Lerrick

Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial.

R. Califf, E. Topol, P. Armstrong, 1998, Journal of the American College of Cardiology.

Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin Fab.

J. Bigger, J. Coromilas, L. Johnson, 1987, Circulation.

Pitfalls of Coronary Angiography in Aortic Dissection—A Case Report

A. Kypson, K. Lerrick, N. Khan, 2011 .

Neurogenic bladder. New clinical finding in Legionnaires' disease.

K. Lerrick, D. Bernardini, M. Lange, 1985, The American journal of medicine.

Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.

W. Frishman, B. Landzberg, K. Lerrick, 1997, Progress in cardiovascular diseases.

Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor.

W. Frishman, K. Lerrick, B. Atac, 1995, American heart journal.